Headquarters
85 WELLS AVE STE 210, NEWTON CENTER, MA 02459-3215, US
NEWTON CENTER, MA, US
From the company
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel cancer therapies. Its core technology leverages inhibition of nuclear export (XPO1 inhibition) and it describes itself as the industry leader in oral Selective Inhibitor of Nuclear Export (SINE) technology.
85 WELLS AVE STE 210, NEWTON CENTER, MA 02459-3215, US
Quantities, certifications, and timing.